Pending approval of a tentative agreement, 5,000 striking nurses at Stanford Health Care and Stanford Children's Health in California could return to work by Tuesday.
from Section Page News - Modern Healthcare https://ift.tt/qlzuah8
Health tips in Tamil and English & more unique news updates too, " Health is wealth " so, Read data and be strong and healthy!!
Pending approval of a tentative agreement, 5,000 striking nurses at Stanford Health Care and Stanford Children's Health in California could return to work by Tuesday.
The 24/7 healthcare provider plans to increase the quality of patient care by expanding access to paramedic and other emergency services.
The agency will crack down on third-party marketing to follow Medicare Advantage policy
Black, American Indian and Alaska Native enrollees ranked lowest on clinical measures among Medicare Advantage beneficiaries, according to a CMS-RAND Corp. study.
The agreement, once finalized, will make SLUCare a dedicated physician division within SSM Health.
The partnership gives Community Health Network physicians access to MD Anderson experts and patients access to innovative cancer treatments, clinical trials and research studies.
Revenue at the medical products giant grew 26% to $3.7 billion in the first quarter.
Public opinion and political will may align to advance fixes to chronic problems with the long-term care system.
Teladoc Health's stock sunk 38% in after-hours trading following its first-quarter earnings release.
Nearly half of Americans suffer from one or more chronic diseases. U.S. life expectancy has dropped more significantly than peer countries. And our healthcare costs are rising faster than anywhere in the world.
Humana, the second-largest Medicare Advantage carrier, expects Medicare Advantage membership to increase by as much as 200,000 this year.
Health officials are keeping a close eye as highly contagious variants continue to spread.
Regulators require Centene to have offices in every service area it operates.
What do we know about the new omicron mutant?
It's a descendant of the earlier super-contagious “stealth omicron” and has quickly gained ground in the United States.
BA.2.12.1 was responsible for 29% of new COVID-19 infections nationally last week, according to data reported Tuesday by the U.S. Centers for Disease Control and Prevention. And it caused 58% of reported infections in the New York region.
The variant has been detected in at least 13 other countries, but the U.S. has the highest levels of it so far. Scientists say it spreads even faster than stealth omicron.
Cases are rising in places with increasing levels of the BA.2.12.1 variant, such as central New York, suggesting something about it is causing it to out-compete others, says Eli Rosenberg of New York state's health department.
It appears a similar pattern will likely play out nationally, says Kirsten St. George, director of virology at New York state’s Wadsworth Center Laboratory.
Scientists are trying to figure out other aspects of BA.2.12.1, including whether vaccines are as effective against it as previous variants.
For Americans of all ages, about 34% had signs of prior infection in December. Just two months later, 58% did.
A Tenet spokesperson declined to comment on how long IT applications were down and how many facilities were affected. At least a subset of Florida hospitals reportedly experienced phone and computer outages.
The research refutes concerns that telehealth could lead to duplicative care.
Epic Systems, followed by Meditech, had the largest growth in U.S. hospital facilities using their electronic health records software last year.
The White House is moving to raise awareness of the pill Paxlovid and taking steps to make it easier to access.
For much of the past two years, America has been first in line for COVID-19 vaccines and treatments. Now, as drugmakers develop the next generation of therapies, the White House is warning that if Congress doesn’t act urgently the U.S. will have to take a number.
A senior administration official said usage of the antiviral regimen has “more than doubled” over the last few weeks, but the administration has more supply at the ready that can save lives and prevent serious disease if prescribed in a timely fashion.
In early April, patient Beth Joyner Waldron received an unexpected call from a man who said he worked for CVS.
Despite success in preventing serious illness and death, there's growing pressure to develop vaccines better at fending off milder infections, too — as well as options to counter scary variants.